A new clue into treatments for triple negative breast cancer, a mean disease
Share
Tweet
November 2, 2017
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
(THE CONVERSATION) When a woman finds a lump in her breast, her doctor’s first move is usually to recommend a biopsy – that is, to remove a small portion of the lump for analysis. If the lump is cancerous, doctors test for three different clinical markers: estrogen receptor, progesterone receptor and human epidermal growth factor receptor. The results determine what kind of hormone or growth factor receptor treatment the patient receives.
About 15-20 percent of breast cancers, thou...
For access to this article please
sign in or
subscribe.
Reader Comments(0)